• Checkpoint Inhibitor CTX-2026 Shows Promising Efficacy in Preclinical Study
  • Newk’s Cares Honors Late Co-founder Lori Newcomb During Awareness Month
  • Pap Smear Samples May Aid Early Diagnosis of Common Ovarian Cancer
  • National Ovarian Cancer Coalition Readies ‘Together in Teal’ Virtual Fundraiser
  • Research Alliance Hopes to Raise $200K During Awareness Month
  • Organ-on-a-chip Device Shows How Cancer Cells Interact With Platelets to Drive Metastasis
  • First Ovarian Cancer Patients Dosed in Phase 2 of OVATION 2 Trial
  • Large-scale Testing of BRCA Mutations Can Be Cost-Effective, Study Finds
  • XMT-1536 on FDA Fast Track for Platinum-resistant, Advanced Ovarian Cancer
  • Partnership Improves Patient Access to Apealea Outside US
  • Study: Tests Used to Predict Response to PARP Inhibitors Yield Inconsistent Result
  • Liposomal Doxorubicin-based Regimen Improves Outcomes in Platinum-sensitive Ovarian Cancer